Analyst Coverage

Analyst Coverage

The following research analysts cover Destiny Pharma.

Mark Brewer, finnCap +44(0)20 7220 0500
Andy Smith, Equity Development +44(0)20 7065 2690


Please click on links below to access coverage published:

finnCap finnCap

Analyst research from finnCap can be obtained by registering on the link above

27 September 2021 – Destiny Pharma – China progress – CMS establishes new dermal programme

Equity Development Equity Development

08 November 2021 – Support on both fronts

27 September 2021 – New dermal collaboration on XF-73

Destiny Pharma - Proactive Proactive Investors

For further commentary and interviews, please visit the Destiny Pharma page at Proactive Investors on the link above